Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes-Reference-Cited by-同舟云学术

Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes

Published:2013-10 Issue:1 Volume:272 Page:245-255
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Doherty Kimberly R.,Wappel Robert L.,Talbert Dominique R.,Trusk Patricia B.,Moran Diarmuid M.,Kramer James W.,Brown Arthur M.,Shell Scott A.,Bacus Sarah

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference49 articles.

1. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy;Cai;J. Am. Coll. Cardiol.,2006

2. Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics;Chen;Circulation,2008

3. Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib;Chu;Lancet,2007

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imatinib‑ and ponatinib‑mediated cardiotoxicity in zebrafish embryos and H9c2 cardiomyoblasts;Molecular Medicine Reports;2024-08-20

2. The involvement of the Stat1/Nrf2 pathway in exacerbating Crizotinib-induced liver injury: implications for ferroptosis;Cell Death & Disease;2024-08-19

3. Predictors of bradycardia in non-small-cell lung cancer patients receiving anaplastic lymphoma kinase inhibitors in a teaching hospital: A retrospective cohort study;2024-05-23

4. Challenging the status quo: a framework for mechanistic and human-relevant cardiovascular safety screening;Frontiers in Toxicology;2024-03-25

5. Involvement of Ferroptosis Induction and Oxidative Phosphorylation Inhibition in the Anticancer-Drug-Induced Myocardial Injury: Ameliorative Role of Pterostilbene;International Journal of Molecular Sciences;2024-03-05